RhythmStar System (SL)
Outpatient Cardiac Telemetry. 510(k) K250793, from RhythMedix, LLC (Mt. Laurel, NJ). Product code QYX, class 2.
As of Nov 17, 2026, K250793 is an FDA 510(k) held by RhythMedix, LLC, substantially equivalent on Apr 21, 2026 after 403 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Apr 21, 2026
- Review time: 403 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe RhythmStar SL System is intended for use by patients who either have or are at risk of having cardiac disease and those that demonstrate intermittent symptoms indicative of cardiac disease and require cardiac monitoring on a continuing basis.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- RhythmStar SystemK233584 · RhythMedix, LLC · Jul 8, 2024
Other QYX Clearances
The newest 510(k)s for the same product code; their median review was 291 days; see every QYX device- Rhythm Express Remote Cardiac Monitoring System (RX-1 mini)K241179 · VivaQuant, Inc. · Jul 11, 2025
- SmartCardia 7L Platform (MCT)K240653 · Smartcardia SA · Oct 31, 2024
- Zio AT® device (A100A1001)K240029 · iRhythm Technologies, Inc. · Oct 21, 2024
- RhythmStar SystemK233584 · RhythMedix, LLC · Jul 8, 2024
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 14, 2025
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1025
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files